News Teva and IBM Watson team up for drug repurposing New three-year deal will use Watson to discover new indications for existing drugs.
News Teva buys US rights to Celltrion biosimilars Israeli firm buys rights to near-copies of Roche blockbusters.
News Teva collaborates with Intel to develop Huntington's smartwa... Teva enters the machine learning market.
News Ultomiris fail mars AZ's strong Q2 results AstraZeneca has served up a robust set of interim results, leavened by strong sales of cancer drugs, but with some mixed pipeline news on the side.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
